# Charles River Laboratories International, Inc. (CRL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CRL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.00B | $ -16.33M | $ 133.79M | $ 3.03B | $ 2.84B |
| 2025 | $ 4.11B | $ -147.79M | $ 530.89M | $ 3.07B | $ 3.16B |
| 2024 | $ 4.26B | $ 10.82M | $ 527.23M | $ 2.72B | $ 3.46B |
| 2023 | $ 4.46B | $ 513.19M | $ 395.06M | $ 3.07B | $ 3.60B |
| 2022 | $ 4.44B | $ 543.17M | $ 329.44M | $ 3.10B | $ 2.98B |
| 2021 | $ 4.21B | $ 464.74M | $ 632.40M | $ 3.21B | $ 2.53B |
| 2020 | $ 3.72B | $ 464.10M | $ 484.11M | $ 2.16B | $ 2.11B |
| 2019 | $ 3.38B | $ 325.29M | $ 439.40M | $ 2.02B | $ 1.63B |
| 2018 | $ 2.99B | $ 298.97M | $ 397.64M | $ 1.70B | $ 1.32B |
| 2017 | $ 2.50B | $ 166.18M | $ 315.01M | $ 1.15B | $ 1.05B |
| 2016 | $ 2.31B | $ 212.93M | $ 334.37M | $ 1.24B | $ 836.77M |
| 2015 | $ 1.91B | $ 209.64M | $ 313.25M | $ 863.03M | $ 733.07M |
| 2014 | $ 1.83B | $ 179.03M | $ 274.30M | $ 777.86M | $ 672.20M |
| 2013 | $ 1.66B | $ 146.25M | $ 238.91M | $ 663.79M | $ 640.98M |
| 2012 | $ 1.63B | $ 140.47M | $ 231.53M | $ 666.52M | $ 600.81M |
| 2011 | $ 1.68B | $ 160.97M | $ 229.39M | $ 717.95M | $ 525.58M |
| 2010 | $ 1.72B | $ -509.77M | $ 191.01M | $ 700.85M | $ 687.42M |
| 2009 | $ 1.82B | $ 173.28M | $ 219.60M | $ 492.83M | $ 1.38B |
| 2008 | $ 2.03B | $ -792.19M | $ 125.47M | $ 576.10M | $ 1.20B |
| 2007 | $ 1.86B | $ 233.79M | $ 86.63M | $ 510.05M | $ 1.86B |
| 2006 | $ 1.65B | $ -84.46M | $ -5.70M | $ 572.06M | $ 1.60B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.07 |
| Liabilities / Eq | 1.65 |
| Current Ratio | 1.35 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 11.07 |
| Gross Debt / FCF | 6.90 |

## Other views

- [Metrics](https://sponda.capital/en/CRL.md)
- [Charts](https://sponda.capital/en/CRL/charts.md)
- [Compare](https://sponda.capital/en/CRL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.